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The “Questionnaire to Assess Adherence to 
Antirretroviral Treatment - HIV” (CEAT-VIH in 
the original) by Remor (2002) [Psicothema, 14, 
(2), 262-267] was developed to evaluate the 
adherence’s degree of individuals living with HIV 
receiving antiretroviral treatment. 
 
Aims and procedures: The main goal of this 
study was the translation and adaptation of the 
CEAT-VIH for the Portuguese context. The 
questionnaire was translated from Spanish to 
Portuguese using the forward-backward 
translation method (Spanish-Portuguese-Spanish), 
followed by a verbal assessment of the items 
comprehension with a heterogeneous group of 
people in terms of age, education and profession.  
The questionnaire translation and adaptation was 
followed by the psychometric study of the 
questionnaire with a 125 patients’ sample with 
antiretroviral treatment for at least three months at 
Joaquim Urbano’s Hospital (Oporto, Portugal). 
 
Results: The results allowed us to identify an 
adequate reliability of the questionnaire (α=0,71) 
and validity related to an external criteria: viral 
load (-0,28; p = 0,001) [viral load was 
logarithmically transformed]. It was also observed 
an adequate sensibility (70,3%) and specificity 
(56,8%) of the questionnaire for the detection of 
the subjects with a detectable viral load. Mean of 
the CEAT-VIH for the current sample was 77,6 
(SD=6,1), median was 78 and range 51 to 89. 
 
Conclusions: Results led us to affirm that the 
Portuguese version of the CEAT-VIH revealed to 
be useful, reliable and valid for the assessment of 
adherence’s degree of the individuals living with 
HIV infection receiving antiretroviral treatment. 
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